Chronic coronary syndrome
Conditions
Interventions
Chronic Coronary Syndrome group:Mark exploration zones check body surface sensitization points observe skin color bumps/depressions nodules and cords. Measure pain thresholds skin temps at sensitized
Control group:Mark exploration zones check body surface sensitization points observe skin color bumps/depressions nodules and cords. Measure pain thresholds skin temps at sensitized points contralater
Sponsors
The Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Chronic Coronary Syndrome group: (1)The patient meets any one of the above diagnostic criteria (2)The patient's activities are not restricted the responses are clear and the compliance is good. (3)The patient is aged between 18 and 85 with no gender restriction. (4)Patients are willing sign an informed consent form. Control group: (1)The subject is aged between 18 and 85 with no gender restriction. (2)The subject has no previous history of chronic coronary syndrome or other heart diseases (3)The subject has no obvious symptoms of discomfort responds clearly and has good compliance. (4)The subjects are willing sign an informed consent form.
Exclusion criteria
Exclusion criteria: Chronic Coronary Syndrome group: (1)Patients suffering from severe cardiac arrhythmias heart failure valvular heart disease congenital heart disease primary cardiomyopathy aortic dissection or other cardiac diseases as well as patients with severe cerebrovascular diseases. (2)Patients with malignant tumors severe hematological diseases severe liver and kidney dysfunction or mental illnesses that prevent cooperation. (3)Patients with a tendency to bleed or allergic constitution. (4)Patients with severe osteoporosis. (5)Patients suffering from shoulder and back pain arm pain caused by muscle strain myofascialitis or cervical and thoracic spine diseases. (6)The patient has skin damage in the examination area and is unable to complete the examination. (7)The patient is a pregnant or lactating woman. (8)Patients who have participated in or are currently participating in other clinical trials within the last 3 months. Control group: (1)The subject has skin damage in the examination area and is unable to complete the examination. (2)The subject is a pregnant or lactating woman. (3)The subjects who have participated in or are currently participating in other clinical trials within the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shape sensitization point; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heat sensitization point;Pain sensitization point; | — |
Countries
China
Contacts
Public ContactQiao Haifa
Shaanxi University of Chinese Medicine
Outcome results
None listed